cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B) mRNA (PDE4B mRNA)

Phosphodiesterase 4B (PDE4B) mRNA is the messenger RNA transcript that encodes the PDE4B enzyme, a member of the cyclic nucleotide phosphodiesterase family responsible for hydrolyzing cyclic adenosine monophosphate (cAMP) (UniProt: Q07343). PDE4B is highly expressed in inflammatory cells, such as macrophages and neutrophils, where it serves as a key regulator of the production of pro-inflammatory cytokines, most notably tumor necrosis factor-alpha (TNF-alpha) (PMID: 15864157). While clinical drugs like Roflumilast and Apremilast are small molecules that inhibit the PDE4B protein, the mRNA itself is an emerging target for RNA-based therapies, such as antisense oligonucleotides and siRNAs, designed to silence gene expression with high specificity (NCBI Gene: 5142). This specificity is critical because pan-PDE4 inhibitors often cause significant gastrointestinal side effects, like nausea and emesis, which are primarily linked to the inhibition of the closely related PDE4D isoform (PMID: 17555401). By targeting the PDE4B mRNA, therapeutic strategies aim to treat chronic inflammatory diseases like chronic obstructive pulmonary disease (COPD), asthma, and psoriasis, as well as neuropsychiatric conditions such as schizophrenia, while minimizing adverse effects (PMID: 24631440).

Other names

Phosphodiesterase 4B mRNADPDE4 mRNAPDEIVB mRNAPDE4B transcriptcAMP-specific 3',5'-cyclic phosphodiesterase 4B

RNA interference (siRNA) or antisense-mediated degradation of the PDE4B transcript to prevent translation of the PDE4B enzyme; alternatively, small-molecule inhibition of the encoded PDE4B protein to prevent cAMP hydrolysis.